1. Home
  2. DC vs OKUR Comparison

DC vs OKUR Comparison

Compare DC & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DC
  • OKUR
  • Stock Information
  • Founded
  • DC 2017
  • OKUR 2011
  • Country
  • DC United States
  • OKUR United States
  • Employees
  • DC N/A
  • OKUR N/A
  • Industry
  • DC Precious Metals
  • OKUR
  • Sector
  • DC Basic Materials
  • OKUR
  • Exchange
  • DC Nasdaq
  • OKUR NYSE
  • Market Cap
  • DC 211.7M
  • OKUR 234.2M
  • IPO Year
  • DC N/A
  • OKUR N/A
  • Fundamental
  • Price
  • DC $2.15
  • OKUR $16.60
  • Analyst Decision
  • DC Buy
  • OKUR Strong Buy
  • Analyst Count
  • DC 1
  • OKUR 2
  • Target Price
  • DC $6.00
  • OKUR $37.50
  • AVG Volume (30 Days)
  • DC 281.2K
  • OKUR 63.1K
  • Earning Date
  • DC 11-13-2024
  • OKUR 11-07-2024
  • Dividend Yield
  • DC N/A
  • OKUR N/A
  • EPS Growth
  • DC N/A
  • OKUR N/A
  • EPS
  • DC N/A
  • OKUR N/A
  • Revenue
  • DC N/A
  • OKUR N/A
  • Revenue This Year
  • DC N/A
  • OKUR N/A
  • Revenue Next Year
  • DC N/A
  • OKUR N/A
  • P/E Ratio
  • DC N/A
  • OKUR N/A
  • Revenue Growth
  • DC N/A
  • OKUR N/A
  • 52 Week Low
  • DC $1.84
  • OKUR $9.80
  • 52 Week High
  • DC $3.25
  • OKUR $77.60
  • Technical
  • Relative Strength Index (RSI)
  • DC 39.84
  • OKUR N/A
  • Support Level
  • DC $2.17
  • OKUR N/A
  • Resistance Level
  • DC $2.60
  • OKUR N/A
  • Average True Range (ATR)
  • DC 0.13
  • OKUR 0.00
  • MACD
  • DC -0.03
  • OKUR 0.00
  • Stochastic Oscillator
  • DC 8.16
  • OKUR 0.00

About DC Dakota Gold Corp.

Dakota Gold Corp is a gold exploration and development company with a specific focus on revitalizing the Homestake District in Lead, South Dakota. Dakota Gold has high-caliber gold mineral properties covering over 48 thousand acres surrounding the historic Homestake Mine.

About OKUR ONKURE THERAPEUTICS INC

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Share on Social Networks: